findmyKOL

Ewa Olech, MD

Enriched profile

Senior Medical Director and Head, Rheumatology Center of Excellence, IQVIA · IQVIA Ltd

ORCIDNPI
Region🇺🇸 Las Vegas, NV · West · United StatesSpecialtyRheumatologyFocusRheumatoid Arthritis
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Ewa Olech is Senior Medical Director and Head, Rheumatology Center of Excellence, IQVIA at IQVIA Ltd. OpenAlex indexes 44 publications with 1,102 citations (h-index 17); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Ewa Olech, MD, is Senior Medical Director and Head, Rheumatology Center of Excellence, IQVIA at IQVIA Ltd. The public record shows 44 publications with 1,102 citations (h-index 17), centered on Rheumatoid Arthritis. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 8 companies.

  • Most recent indexed publication: 2023 · Arthritis research & therapy
  • Top research focus: Rheumatoid Arthritis
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 8 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Rheumatoid Arthritis2 trials

Research focus

OpenAlex concept fingerprint
Rheumatoid Arthritis

Drugs & molecules

across trials, industry payments and publications
Xeljanzgeneric · TofacitinibClinical trialsIndustry payments8Publications1Rinvoqgeneric · UpadacitinibClinical trialsIndustry payments149PublicationsSkyrizigeneric · RisankizumabClinical trialsIndustry payments38Publications

Works with

trial sponsors and companies reporting payments
Abbvie Inc.Clinical trialsIndustry payments180Pfizer Inc.Clinical trialsIndustry payments8Amgen Inc.Clinical trialsIndustry payments4

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
44publications

Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.

1,102citations

Total citations across indexed works.

17h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials
8companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

8 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    100%
    TNF inhibitor100%
    Enbrel Sureclick100%
    Part D<11 patients

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • LinkedIn

    linkedin.com/in/ewa-olech-md-rheum-ok-11475726

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
  • ResearchGate

    researchgate.net/profile/Ewa-Olech

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net
  • ResearchGate

    researchgate.net/profile/Ewa-Olech-2

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net
2 more verified accounts behind the reveal.Reveal →

Mentions by others

where others cite or feature them
  • Other

    acr23.eventscribe.net/fsPopup.asp

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acr23.eventscribe.net
  • Other

    steritas.com/insights/in-conversation-with-ewa-olech-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →steritas.com
  • LinkedIn

    LinkedIn profile listing IQVIA affiliation (auth-walled; corroborated via SERP snippet only)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • University of Nevada

    Las Vegas, Associate Professor of Medicine & Rheumatology Division Chair

    2016
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pub.orcid.org
  • Rheumatology Consultants

    PLLC (clinical practice), Las Vegas, NV

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →acr23.eventscribe.net

Media & interviews

press, podcasts and appearances
  • Presenter

    ACR Convergence 2023 (American College of Rheumatology annual meeting)

    2023
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acr23.eventscribe.net
  • "In Conversation With… Ewa Olech, MD"

    Steritas interview feature

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →steritas.com

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.